THREE-YEAR ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS
- Trine Alma Knudsen (Foredragsholder)
- Lund Hansen, D. (Andet)
- Lucas Frans Ocias (Andet)
- Weiss Bjerrum, O. (Andet)
- Brabrand, M. (Andet)
- Christina Ellervik (Andet)
- Daniel el Fassi (Andet)
- Frederiksen, M. (Andet)
- Lasse Kjær (Andet)
- Thomas Kielsgaard Kristensen (Andet)
- Kruse, T. A. (Underviser)
- Hans Torben Mourits-Andersen (Andet)
- Peter Møller (Andet)
- Ulrik Malthe Overgaard (Andet)
- Dustin Andersen Patel (Andet)
- Marianne Tang Severinsen (Andet)
- Vibe Skov (Andet)
- Anders Lindholm Sørensen (Andet)
- Stentoft Jesper (Andet)
- Jørn Starklint (Andet)
- Karin de Stricker (Andet)
- Thomassen, M. (Andet)
- Larsen, T. S. (Underviser)
- C Hasselbalc Hans (Andet)
Aktivitet: Foredrag og mundtlige bidrag › Konferenceoplæg